These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36746063)

  • 1. Biomimetic nanovaccine based on erythrocyte membrane enhances immune response and protection against tilapia lake virus.
    Wei XF; Gong YM; Xia JY; Liu MZ; Li PF; Wang GX; Zhu B
    Virology; 2023 Mar; 580():41-49. PubMed ID: 36746063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan nanoparticle immersion vaccine offers protection against tilapia lake virus in laboratory and field studies.
    Tattiyapong P; Kitiyodom S; Yata T; Jantharadej K; Adamek M; Surachetpong W
    Fish Shellfish Immunol; 2022 Dec; 131():972-979. PubMed ID: 36351543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Phage Display Technology with
    Gong YM; Wei XF; Zheng YY; Li Y; Yu Q; Li PF; Zhu B
    J Virol; 2023 Apr; 97(4):e0005023. PubMed ID: 36975794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tilapia develop protective immunity including a humoral response following exposure to tilapia lake virus.
    Tattiyapong P; Dechavichitlead W; Waltzek TB; Surachetpong W
    Fish Shellfish Immunol; 2020 Nov; 106():666-674. PubMed ID: 32858185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining segments 9 and 10 in DNA and recombinant protein vaccines conferred superior protection against tilapia lake virus in hybrid red tilapia (
    Chamtim P; Suwan E; Dong HT; Sirisuay S; Areechon N; Wangkahart E; Hirono I; Mavichak R; Unajak S
    Front Immunol; 2022; 13():935480. PubMed ID: 35958595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of heat-killed and formalin-killed vaccines against Tilapia tilapinevirus in juvenile Nile tilapia (Oreochromis niloticus).
    Mai TT; Kayansamruaj P; Taengphu S; Senapin S; Costa JZ; Del-Pozo J; Thompson KD; Rodkhum C; Dong HT
    J Fish Dis; 2021 Dec; 44(12):2097-2109. PubMed ID: 34477227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tilapia lake virus (TiLV) causes severe anaemia and systemic disease in tilapia.
    Turner JK; Sakulpolwat S; Sukdanon S; Lertwanakarn T; Waiyamitra P; Piewbang C; Pierezan F; Techangamsuwan S; Soto E; Surachetpong W
    J Fish Dis; 2023 Jun; 46(6):643-651. PubMed ID: 36848441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-polymer based nanovaccine as promising immersion vaccine against Aeromonas veronii challenge in red tilapia (Oreochromis sp.).
    Sukkarun P; Kitiyodom S; Yostawornkul J; Chaiin P; Yata T; Rodkhum C; Boonrungsiman S; Pirarat N
    Fish Shellfish Immunol; 2022 Oct; 129():30-35. PubMed ID: 35988712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tilapia lake virus (TiLV): Genomic epidemiology and its early origin.
    Thawornwattana Y; Dong HT; Phiwsaiya K; Sangsuriya P; Senapin S; Aiewsakun P
    Transbound Emerg Dis; 2021 Mar; 68(2):435-444. PubMed ID: 32578388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tilapia Lake Virus Vaccine Development: A Review on the Recent Advances.
    Kembou-Ringert JE; Steinhagen D; Readman J; Daly JM; Adamek M
    Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and purification of S5
    Lueangyangyuen A; Senapin S; Dong HT; Unajak S; Wangkahart E; Khunrae P
    Protein Expr Purif; 2022 Feb; 190():106013. PubMed ID: 34752859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell Culture-Derived Tilapia Lake Virus-Inactivated Vaccine Containing Montanide Adjuvant Provides High Protection against Viral Challenge for Tilapia.
    Zeng W; Wang Y; Hu H; Wang Q; Bergmann SM; Wang Y; Li B; Lv Y; Li H; Yin J; Li Y
    Vaccines (Basel); 2021 Jan; 9(2):. PubMed ID: 33503930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the mucosal immune response of red tilapia (Oreochromis sp.) against columnaris disease using a biomimetic-mucoadhesive nanovaccine.
    Kitiyodom S; Trullàs C; Rodkhum C; Thompson KD; Katagiri T; Temisak S; Namdee K; Yata T; Pirarat N
    Fish Shellfish Immunol; 2021 May; 112():81-91. PubMed ID: 33675991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibilities of ten fish cell lines to infection with Tilapia lake virus.
    Li B; Zheng S; Wang Y; Wang Q; Li Y; Yin J; Ren Y; Shi C; Zhao Z; Jiang Z; Bergmann SM; Zeng W
    Microb Pathog; 2022 May; 166():105510. PubMed ID: 35421555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a Novel Orthomyxo-like Virus Causing Mass Die-Offs of Tilapia.
    Bacharach E; Mishra N; Briese T; Zody MC; Kembou Tsofack JE; Zamostiano R; Berkowitz A; Ng J; Nitido A; Corvelo A; Toussaint NC; Abel Nielsen SC; Hornig M; Del Pozo J; Bloom T; Ferguson H; Eldar A; Lipkin WI
    mBio; 2016 Apr; 7(2):e00431-16. PubMed ID: 27048802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tilapia lake virus disease: Phylogenetic analysis reveals that two distinct clades are circulating in Israel simultaneously.
    Skornik R; Eyngor M; Behar A; Markovich MP; Wajsbrot N; Klement E; Davidovich N
    Transbound Emerg Dis; 2020 Mar; 67(2):494-501. PubMed ID: 31667996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal risk of tilapia lake virus transmission via frozen tilapia fillets.
    Thammatorn W; Rawiwan P; Surachetpong W
    J Fish Dis; 2019 Jan; 42(1):3-9. PubMed ID: 30468255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of Nile Tilapia (
    Mai TT; Kayansamruaj P; Soontara C; Kerddee P; Nguyen DH; Senapin S; Costa JZ; Del-Pozo J; Thompson KD; Rodkhum C; Dong HT
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental infection of Tilapia Lake Virus (TiLV) in Nile tilapia (Oreochromis niloticus) and red tilapia (Oreochromis spp.).
    Tattiyapong P; Dachavichitlead W; Surachetpong W
    Vet Microbiol; 2017 Aug; 207():170-177. PubMed ID: 28757020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficacy of immersion vaccination in tilapia against columnaris disease by chitosan-coated "pathogen-like" mucoadhesive nanovaccines.
    Kitiyodom S; Yata T; Yostawornkul J; Kaewmalun S; Nittayasut N; Suktham K; Surassmo S; Namdee K; Rodkhum C; Pirarat N
    Fish Shellfish Immunol; 2019 Dec; 95():213-219. PubMed ID: 31585248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.